Authors
Loading...
Service evaluation reveals 67.3% adequate sample collection for whole genome sequencing in brain tumour patients, indicating effective clinical workflow.
Carter et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: